Nutex Health (NASDAQ:NUTX) Price Target Raised to $50.00

Nutex Health (NASDAQ:NUTX) had its target price upped by Maxim Group from $45.00 to $50.00 in a report published on Tuesday, MarketBeat.com reports. They currently have a buy rating on the stock.

Separately, Benchmark lifted their target price on Nutex Health from $30.00 to $45.00 and gave the company a “buy” rating in a research report on Wednesday, August 21st.

Nutex Health Trading Down 7.3 %

Shares of NUTX traded down $2.30 during mid-day trading on Tuesday, reaching $29.03. 14,616 shares of the company’s stock traded hands, compared to its average volume of 42,590. The company has a debt-to-equity ratio of 3.36, a current ratio of 1.77 and a quick ratio of 1.55. The stock’s 50-day moving average is $23.19 and its two-hundred day moving average is $13.95. Nutex Health has a 12 month low of $4.16 and a 12 month high of $39.48. The stock has a market cap of $157.92 million, a P/E ratio of -3.09 and a beta of 0.11.

Insider Activity at Nutex Health

In other Nutex Health news, CFO Jon Christian Bates purchased 1,350 shares of Nutex Health stock in a transaction on Thursday, August 22nd. The stock was bought at an average cost of $21.46 per share, with a total value of $28,971.00. Following the transaction, the chief financial officer now owns 2,277 shares of the company’s stock, valued at $48,864.42. This represents a 145.63 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 38.52% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of NUTX. Essex Investment Management Co. LLC acquired a new position in shares of Nutex Health in the third quarter worth about $1,579,000. International Assets Investment Management LLC purchased a new position in Nutex Health during the third quarter worth approximately $188,000. Finally, Thompson Davis & CO. Inc. acquired a new stake in Nutex Health in the third quarter valued at approximately $494,000. 5.32% of the stock is owned by institutional investors and hedge funds.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.